Barrett & Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Barrett & Company’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$252K	Buy	925 +20	+2%	+$5.2K	0.07%	140
2026 Q2	$224K	Hold	905	–	–	0.06%	156
2026 Q1	$182K	Hold	905	–	–	0.06%	161
2025 Q4	$187K	Hold	905	–	–	0.06%	156
2025 Q3	$162K	Hold	905	–	–	0.06%	170
2025 Q2	$146K	Sell	905 -55	-6%	-$8.76K	0.05%	173
2025 Q1	$163K	Hold	960	–	–	0.07%	150
2024 Q4	$160K	Hold	960	–	–	0.07%	153
2024 Q3	$165K	Hold	960	–	–	0.07%	150
2024 Q2	$148K	Hold	960	–	–	0.07%	158
2024 Q1	$148K	Hold	960	–	–	0.07%	154
2023 Q4	$152K	Hold	960	–	–	0.08%	143
2023 Q3	$140K	Hold	960	–	–	0.08%	142
2023 Q2	$147K	Hold	960	–	–	0.09%	144
2023 Q1	$149K	Hold	960	–	–	0.09%	143
2022 Q4	$148K	Hold	960	–	–	0.1%	134
2022 Q3	$148K	Buy	+960	New	+$135K	0.1%	134

Other funds holding FBT

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return

Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return

B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return

Ocean Park Asset Management Santa Monica, California $1.65B AUM 1.83% 1-Year Est. Return

Barrett & Company's FBT Position: Q3 2026 in Review

Barrett & Company increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.2% in Q3 2026, buying an estimated $5.2K and bringing the position to 925 shares worth $252K. The position accounts for 0.07% of the portfolio, ranked #140.

Barrett & Company first reported a position in FBT in Q3 2022 and has held it in 17 quarters since. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

Barrett & Company held 925 shares of First Trust NYSE Arca Biotechnology Index Fund worth $252K as of Q3 2026.
Barrett & Company bought 20 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $5.2K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.07% of Barrett & Company's portfolio in Q3 2026, its #140 holding.
Barrett & Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and has held it in 17 quarters since.
98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.